Science · Article
Warhound: Startup Raises $200M to Genetically Engineer Dogs for the US Military
Published:

In brief
Warhound, co-founded by Colossal Biosciences' Ben Lamm and Anduril's Palmer Luckey, raised $200 million on October 22, 2026 to genetically edit and clone dogs for the US military, aiming to remove inherited diseases from breeds such as the Belgian Malinois. Independent scientists call the genetic goals technically achievable, but bioethicists warn that cloning remains inefficient and raises unresolved animal-welfare and regulatory questions.
A Texas-based startup called Warhound announced on October 22, 2026 that it had raised $200 million in funding to genetically modify and clone dogs for the US military, law enforcement and first-responder agencies, according to TechCrunch. The company was founded by Ben Lamm, chief executive of de-extinction firm Colossal Biosciences, together with Anduril co-founder Palmer Luckey, who holds no equity in the venture but acts as a partner.
Who is behind Warhound, and who is paying for it
TechCrunch reported the funding round values Warhound at $1.2 billion and lists Sequoia, 8VC, Corner Ventures and In-Q-Tel — the CIA's venture-capital arm — among the investors. David Spirk, previously of data-analytics firm Palantir, was named chief executive, according to Engadget. At launch the company had not signed any customers or set prices for its dogs, Winbuzzer reported.
Why the US military says it needs new working dogs
TechCrunch reported that more than 80% of US military working dogs are currently imported from Europe, and that fewer than half of the dogs acquired are ultimately fit for service. Warhound's stated goal is to build a domestic supply chain of healthier dogs with higher pass rates, according to TechCrunch.
What genetic changes are planned, and what Anduril adds
According to TechCrunch and Engadget, Warhound collected cell samples from top-performing US military, police and first-responder dogs — primarily Belgian Malinois, with some German Shepherds and Labradors — to clone and genetically modify. The initial edits target genes linked to hip dysplasia, certain cancers, eye disease and muscle atrophy; later changes could target speed, agility and scent detection, the outlets reported.
Anduril is not altering the dogs' biology. Per TechCrunch and Winbuzzer, the defense company is instead building protective gear and software — sensor-equipped vests, goggles and handler-communication tools — meant to improve coordination and safety once the dogs are deployed.
The ethical and welfare questions scientists are raising
Scientific American interviewed independent researchers who said Warhound's genetic targets are scientifically plausible. Ben Novak, chief scientist at Revive & Restore, noted that extensive canine genomic data already exists, though many traits result from combinations of hundreds or thousands of gene variants, complicating large-scale optimization. Robert Lanza, former chief scientific officer at the Astellas Institute for Regenerative Medicine, said the goals are achievable from a scientific perspective but would likely involve repeated failures along the way.
Cloning requires a lot of dogs to have invasive things done to them and to be killed in order to produce one cloned puppy.
Moses told Scientific American that cloning remains an inefficient process and that mixing dogs with biotechnology quickly becomes ethically fraught, partly because public expectations around animals differ from those around other genetically engineered organisms. She also pointed to uncertainty over the long-term health effects of specific edits, including those targeting hip dysplasia.
Writing in Mother Jones, a reporter placed Warhound within a wider pattern of Silicon Valley ventures pursuing genetic "optimization," drawing a comparison to Colossal's earlier marketing of genetically altered gray wolves as resurrected "dire wolves." The article did not include on-record criticism from animal-welfare groups or independent bioethicists beyond the feasibility assessments cited elsewhere.
| Metric | Figure | Source |
|---|---|---|
| Funding raised | $200 million | TechCrunch, Oct 22, 2026 |
| Valuation at launch | $1.2 billion | TechCrunch |
| US military dogs imported from Europe | Over 80% | TechCrunch |
| Imported dogs that pass training | Fewer than half | TechCrunch |
| 2018 South Korean cloned-dog test (cloned vs. conventionally bred) | 6 of 6 cloned Labradors passed detector tests vs. 1 of 4 conventionally bred | Winbuzzer |
| Historical embryo-to-puppy cloning efficiency | 1.7%–3.8% of transferred embryos | Winbuzzer |
| Expected first genetically modified puppies | Early 2027 | TechCrunch, Winbuzzer |
Timeline and outside oversight
TechCrunch and Winbuzzer reported that Warhound expects its first cloned, gene-edited puppies in early 2027, with a goal of placing trained dogs into service within about two years. Winbuzzer reported that the American Humane Society, led by chief executive Robin Ganzert, is set to certify Warhound's training programs and oversee welfare from training through retirement, including rehoming or adoption arrangements for retired dogs.
As of the October 2026 announcement, Warhound's dogs did not yet exist, meaning claims about their eventual welfare, performance and battlefield behavior remain untested, a point Mother Jones and Scientific American both underscored in their coverage.
Questions
- What is Warhound?
- Warhound is a US startup, co-founded by Colossal Biosciences' Ben Lamm and Anduril's Palmer Luckey, that plans to genetically modify and clone dogs for the US military, law enforcement and first responders, according to TechCrunch.
- How much funding did Warhound raise, and from whom?
- The company raised $200 million in funding valuing it at $1.2 billion, with investors including Sequoia, 8VC, Corner Ventures and In-Q-Tel, TechCrunch reported.
- What genetic changes will be made to the dogs?
- Initial edits target genes linked to hip dysplasia, certain cancers, eye problems and muscle atrophy in breeds such as the Belgian Malinois; later work could target speed, agility and scent detection, per TechCrunch and Engadget.
- Why are scientists and bioethicists concerned about this project?
- Scientific American reported that while the genetic goals appear technically feasible, cloning remains inefficient and can require many dogs to undergo invasive procedures to produce one puppy, a concern raised by Harvard bioethicist Lisa Moses, who also cited uncertainty over long-term effects of the gene edits.
- When will the first genetically modified military dogs be ready?
- Warhound expects its first cloned, gene-edited puppies to be born in early 2027, with trained dogs targeted for service roughly two years later, according to TechCrunch and Winbuzzer.
Sources
- TechCrunch — Warhound raises $200M to engineer war dogs and arm them with Anduril gear
- Scientific American — Warhound wants to engineer and clone military super-dogs — can they do it?
- Mother Jones — Palmer Luckey is launching a genetically engineered war dog startup
- Engadget — A startup called Warhound is genetically engineering dogs for the military
- Winbuzzer — Warhound raises $200M to develop gene-edited military dogs
This piece was prepared with artificial intelligence and passed an automated source check before publication. If you see an error, ask for a correction. Request a correction or reply · How we make this
Related

ScienceArticle
Photosynthesis Explained: How Plants Turn Sunlight Into Chemical Energy
Photosynthesis is the process by which plants, algae and some bacteria use sunlight, water and carbon dioxide to make sugar and oxygen. It happens in two linked stages inside chloroplasts: light-dependent reactions that capture solar energy, and the Calvin cycle that uses that energy to build carbohydrates.

ScienceArticle
How Vaccines Work: From Lab Development to Immune Protection
Vaccines work by showing the immune system a harmless piece of a pathogen — called an antigen — so the body builds antibodies and memory cells without suffering the actual disease. Getting a vaccine to that point takes years of preclinical testing and three phases of human trials before regulators such as the FDA license it. Full protection after vaccination typically takes a few weeks, as the immune system needs time to produce lasting defenses.

ScienceArticle
Why the World Is Abolishing the Leap Second, and What Changes in 2027
Leap seconds, the one-second adjustments used since 1972 to keep clocks aligned with Earth's rotation, will stop entirely. The world's timekeeping authority, the International Bureau of Weights and Measures (BIPM), confirmed on 15 October 2026 that continuous UTC takes effect on 20 May 2027. The move, first agreed in principle in 2022, was accelerated after experts flagged a growing risk of a disruptive "negative" leap second.

ScienceArticle
Leap Seconds Explained: How World Time Works and Why They're Being Scrapped
A leap second is a one-second correction added to Coordinated Universal Time (UTC) to keep it within 0.9 seconds of Earth's actual rotation. On 15 October 2026 the General Conference on Weights and Measures (CGPM) voted to stop inserting leap seconds from 20 May 2027, letting UTC drift from Earth's rotation by up to one hour instead of one second.